Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Rukobia 600 mg prolonged-release tablets {equilateral_black_triangle}

Active Ingredient:
fostemsavir tromethamine
Company:  
ViiV Healthcare UK Ltd See contact details
ATC code: 
J05AX29
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Live Chat HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 26 Apr 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
ViiV Healthcare UK Ltd
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
+44 (0)800 221 441